Splisense
Tamar Mordechai is a Research Associate at SpliSense since June 2021, bringing experience from previous roles as a Laboratory Technician at The Hebrew University of Jerusalem and a Laboratory Assistant at The Hebrew University High School. Tamar holds a Master of Science degree in Biomedical Science with a focus on Cell Biology, Immunology, and Cancer Research from The Hebrew University of Jerusalem, completed between 2018 and 2020, and a Bachelor of Science degree in Medical Laboratory Sciences from Hadassah Academic College, attained from 2014 to 2017.
This person is not in the org chart
This person is not in any teams
Splisense
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.